India · Delayed Price · Currency is INR Nectar Lifesciences Statistics
Total Valuation
BOM:532649 has a market cap or net worth of INR 3.20 billion. The enterprise value is 8.82 billion.
| Market Cap | 3.20B |
| Enterprise Value | 8.82B |
Important Dates
The last earnings date was Tuesday, August 12, 2025.
| Earnings Date | Aug 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 224.26M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.58% |
| Shares Change (QoQ) | -0.03% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 112.69M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.20 |
| PB Ratio | 0.33 |
| P/TBV Ratio | 0.36 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.90 |
| EV / Sales | 0.55 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.61 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.61 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -7.39% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 8.91M |
| Profits Per Employee | -1.01M |
| Employee Count | 1,686 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -833.25M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -64.18% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -64.18% |
| 50-Day Moving Average | 17.80 |
| 200-Day Moving Average | 27.08 |
| Relative Strength Index (RSI) | 36.93 |
| Average Volume (20 Days) | 85,992 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:532649 had revenue of INR 15.92 billion and -1.80 billion in losses. Loss per share was -8.06.
| Revenue | 15.92B |
| Gross Profit | 1.98B |
| Operating Income | -1.92B |
| Pretax Income | -2.63B |
| Net Income | -1.80B |
| EBITDA | -1.29B |
| EBIT | -1.92B |
| Loss Per Share | -8.06 |
Balance Sheet
The company has 197.51 million in cash and 5.82 billion in debt, giving a net cash position of -5.62 billion.
| Cash & Cash Equivalents | 197.51M |
| Total Debt | 5.82B |
| Net Cash | -5.62B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 9.56B |
| Book Value Per Share | 42.63 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 12.41%, with operating and profit margins of -12.04% and -11.30%.
| Gross Margin | 12.41% |
| Operating Margin | -12.04% |
| Pretax Margin | -16.54% |
| Profit Margin | -11.30% |
| EBITDA Margin | -8.09% |
| EBIT Margin | -12.04% |
| FCF Margin | n/a |
Dividends & Yields
BOM:532649 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.58% |
| Shareholder Yield | n/a |
| Earnings Yield | -56.21% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 12, 2008. It was a forward split with a ratio of 10.
| Last Split Date | Nov 12, 2008 |
| Split Type | Forward |
| Split Ratio | 10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |